Whitfield Roy A (CIK 0000936728)

Latest company ownership

Shares held
8,000
Last filed at
Oct 1, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 14, 2023 Jun 15, 2023 NEKTAR THERAPEUTICS Director Sell 32.5 -30,000 -9.44% $17.1K
Jun 5, 2018 Jun 7, 2018 NEKTAR THERAPEUTICS Director Buy 90.0 +5,000 2.60% $290.2K
Aug 10, 2017 Aug 14, 2017 NEKTAR THERAPEUTICS Director Buy 97.5 +35,000 29.66% $628.3K